Kalindi Overseas Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Kalindi Overseas Pharmaceutical Export Portfolio Dataset — 5 Products, $228.0K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kalindi Overseas — Pharmaceutical Exporter Profile (2026) | 5 Products, $228.0K Trade | TransData Nexus

Product Portfolio — Top 5 by Export Value

Kalindi Overseas exports 5 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Mefloquine	Antimalarial & Antiparasitic	$116.7K	22	4.8%	2
2	Proguanil	Antimalarial & Antiparasitic	$45.0K	20	0.0%	8
3	Atovaquone	Antimalarial & Antiparasitic	$38.6K	10	0.0%	8
4	Ibrutinib	Advanced Oncology	$20.6K	19	2.0%	9
5	Volini	Brand Names & OTC Products	$7.2K	66	0.2%	10

Kalindi Overseas exports 5 pharmaceutical products across 3 therapeutic categories with a total export value of $228.0K. The top category is Antimalarial & Antiparasitic (87.8% of portfolio), followed by Advanced Oncology (9.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Kalindi Overseas — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Kalindi Overseas is an Indian pharmaceutical exporter specializing in finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Established in 2004, the company is headquartered in Kandivali (West), Mumbai, Maharashtra. It operates as a private limited company, with a small team of 1 to 5 employees. The company's annual revenue is less than USD 100,000. Kalindi Overseas is registered under the Corporate Identification Number (CIN) U51909DL1977PTC008479, with an authorized capital of ₹500,000 and a paid-up capital of ₹2,000. The company's registered office is located at 8-B, Jindal Charitable Trust Building, Asaf Ali Road, New Delhi-1, Delhi, India.

2Manufacturing Facilities

Specific details regarding Kalindi Overseas' manufacturing facilities are not publicly available. The company is primarily engaged in the export of finished pharmaceutical formulations, suggesting that it may source products from third-party manufacturers or contract manufacturing organizations. Without publicly disclosed information, a comprehensive assessment of their manufacturing capabilities cannot be provided.

3Key Leadership

Information about the key leadership of Kalindi Overseas is not publicly disclosed. The company's registered office is located at 8-B, Jindal Charitable Trust Building, Asaf Ali Road, New Delhi-1, Delhi, India. However, specific details regarding the CEO, CFO, or other key executives are not available in the public domain.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Kalindi Overseas Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Kalindi Overseas' presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not publicly documented. The company specializes in exporting finished pharmaceutical formulations, but specific regulatory filings, approvals, or market access statuses in these regions are not available. Without publicly disclosed information, a detailed analysis of their regulatory standing in these markets cannot be provided.

2Emerging Markets

Kalindi Overseas' penetration into emerging markets, including Africa, Latin America, and Southeast Asia, is not publicly documented. The company specializes in exporting finished pharmaceutical formulations, but specific details regarding market presence or WHO prequalification status are not available. Without publicly disclosed information, an assessment of their activities in these regions cannot be provided.

3Geographic Strategy

Kalindi Overseas' geographic strategy appears to be focused on exporting finished pharmaceutical formulations. However, specific details regarding their market diversification, concentration risk, or strategic direction are not publicly available. Without publicly disclosed information, a comprehensive assessment of their geographic strategy cannot be provided.

Kalindi Overseas — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Kalindi Overseas' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history are not publicly available. The company's focus on exporting finished pharmaceutical formulations suggests that it may source products from third-party manufacturers. Without publicly disclosed information, a detailed analysis of their FDA status cannot be provided.

2WHO & EU GMP

Information regarding Kalindi Overseas' WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly available. The company's specialization in exporting finished pharmaceutical formulations indicates that it may source products from third-party manufacturers. Without publicly disclosed information, an assessment of their compliance with WHO and EU GMP standards cannot be provided.

3CDSCO & Indian Regulatory

Kalindi Overseas — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Specific information regarding Kalindi Overseas' competitors in overlapping categories, market share comparisons, or head-to-head analyses is not publicly available. The company's focus on exporting finished pharmaceutical formulations suggests that it operates in a competitive market. However, without publicly disclosed information, a comprehensive assessment of the competitive landscape cannot be provided.

2Key Differentiators

Kalindi Overseas' key differentiators are not publicly documented. The company's specialization in exporting finished pharmaceutical formulations indicates a focus on providing a range of products to meet diverse market needs. However, without publicly disclosed information, a detailed analysis of their unique strengths or competitive advantages cannot be provided.

3Strategic Position

Kalindi Overseas' current strategic direction appears to be focused on exporting finished pharmaceutical formulations. However, specific details regarding their focus on generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services are not publicly available. Without publicly disclosed information, a comprehensive assessment of their strategic position and future outlook cannot be provided.

Buyer Due Diligence Brief — Evaluating Kalindi Overseas as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Specific details regarding Kalindi Overseas' track record, export volume and consistency, or reliability indicators are not publicly available. The company's specialization in exporting finished pharmaceutical formulations suggests a focus on providing a range of products to meet diverse market needs. However, without publicly disclosed information, a comprehensive assessment of their supplier performance cannot be provided.

2Certifications to Verify

Importers should verify the following certifications when considering Kalindi Overseas as a supplier:

FDA Registration: To ensure compliance with U.S. regulations, verify the FDA registration status of the manufacturing facilities. This can be done by checking the FDA's official database or contacting the FDA directly.

WHO-GMP Certification: To confirm adherence to international manufacturing standards, verify the WHO-GMP certification of the manufacturing facilities. This can be done by consulting the World Health Organization's official website or contacting them directly.

Frequently Asked Questions — Kalindi Overseas

How many pharmaceutical products does Kalindi Overseas export from India?

Kalindi Overseas exports 5 pharmaceutical products across 3 therapeutic categories. The top exports are Mefloquine ($116.7K), Proguanil ($45.0K), Atovaquone ($38.6K), Ibrutinib ($20.6K), Volini ($7.2K). Total export value is $228.0K.

What is Kalindi Overseas's total pharmaceutical export value?

Kalindi Overseas's total pharmaceutical export value is $228.0K, based on 137 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Kalindi Overseas cover?

Kalindi Overseas exports across 3 therapeutic categories. The largest are Antimalarial & Antiparasitic (87.8%, 3 products), Advanced Oncology (9.0%, 1 products), Brand Names & OTC Products (3.1%, 1 products).

Get Full Kalindi Overseas Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Kalindi Overseas

Kalindi Overseas — Export Portfolio & Destination Treemap

Who is Kalindi Overseas? — Company Overview & Market Position

What Does Kalindi Overseas Export? — Product Portfolio Analysis

Top Products by Export Value

Kalindi Overseas Therapeutic Categories — 3 Specializations